The BPC-157 dosage ranges that emerge from this literature, 200 to 500 micrograms per day in humans, administered by the route most appropriate to the target tissue, represent the best available clinical translation of that science
Roberts LA, Beattie K, Close GL, Morton JP
Sources: Khavinson V, et al
Unlike some peptides that work immediately (like PT-141 for acute effects), the glow stack peptides build effects over time
Major market drivers include heightened consumer awareness of oxidative stress and cellular health, the pursuit of rapid detoxification and aesthetic benefits, and the professionalization of the IV therapy provider network
& Stockwell, B.R